| Authors: |
Jiang T; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Markovic D; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA., Patel J; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Juarez JE; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Ma TM; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Shabsovich D; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Nickols NG; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Reiter RE; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Elashoff D; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA., Rettig MB; Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Division of Hematology and Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Zaorsky NG; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Kishan AU; Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. aukishan@mednet.ucla.edu.; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. aukishan@mednet.ucla.edu. |
